SAA1 and neoplasm: As SAA1 is a biomarker which can be detected not only in blood but also in a tumor sample, it was independent of other ccRCC clinicopathological features, which indicated that SAA1 could predict the outcome of a ccRCC patient pre-operation according to the expression of SAA1 in the biopsy or blood samples.